Jacmar: Usually I pick up on sarcasm pretty well, but I'm not sure I'm reading this right. I think you're making fun of my speculating whether recombinant MANF injections may be involved in the treatment of wolframs and diabetes?

Shareholders for a long time have speculated on this, based on Urano's recent comments about hoping he has found another alternative, why is my speculation irrelevant? It seems very appropriate.

All anyone does on this mb is speculate. Special rules apply to me?